EcoR1 Capital’s Neurogene NGNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $19M | Hold |
1,271,342
| – | – | 1.13% | 18 |
|
|
2025
Q1 | $14.9M | Hold |
1,271,342
| – | – | 0.88% | 20 |
|
|
2024
Q4 | $29.1M | Hold |
1,271,342
| – | – | 1.1% | 19 |
|
|
2024
Q3 | $53.3M | Hold |
1,271,342
| – | – | 1.83% | 14 |
|
|
2024
Q2 | $46.3M | Hold |
1,271,342
| – | – | 1.42% | 20 |
|
|
2024
Q1 | $64.7M | Hold |
1,271,342
| – | – | 1.64% | 19 |
|
|
2023
Q4 | $24.6M | Buy |
+1,271,342
| New | +$24.6M | 0.64% | 28 |
|
|
2022
Q1 | – | Sell |
-43,031
| Closed | -$4.15M | – | 93 |
|
|
2021
Q4 | $4.15M | Hold |
43,031
| – | – | 0.13% | 49 |
|
|
2021
Q3 | $6.22M | Sell |
43,031
-74,909
| -64% | -$10.8M | 0.22% | 37 |
|
|
2021
Q2 | $21.8M | Sell |
117,940
-38,195
| -24% | -$7.05M | 0.81% | 27 |
|
|
2021
Q1 | $38.4M | Hold |
156,135
| – | – | 1.7% | 17 |
|
|
2020
Q4 | $44M | Sell |
156,135
-37,012
| -19% | -$10.4M | 2.37% | 15 |
|
|
2020
Q3 | $46.4M | Buy |
193,147
+16,313
| +9% | +$3.92M | 3.31% | 10 |
|
|
2020
Q2 | $58.7M | Sell |
176,834
-7,826
| -4% | -$2.6M | 4.34% | 10 |
|
|
2020
Q1 | $42M | Sell |
184,660
-11,134
| -6% | -$2.53M | 4.39% | 8 |
|
|
2019
Q4 | $48.2M | Buy |
195,794
+82,500
| +73% | +$20.3M | 4.35% | 9 |
|
|
2019
Q3 | $6.46M | Hold |
113,294
| – | – | 0.82% | 22 |
|
|
2019
Q2 | $5.35M | Hold |
113,294
| – | – | 0.54% | 27 |
|
|
2019
Q1 | $6.11M | Hold |
113,294
| – | – | 0.56% | 31 |
|
|
2018
Q4 | $4.89M | Hold |
113,294
| – | – | 0.49% | 33 |
|
|
2018
Q3 | $6.64M | Buy |
113,294
+55,794
| +97% | +$3.27M | 0.6% | 24 |
|
|
2018
Q2 | $3.05M | Buy |
+57,500
| New | +$3.05M | 0.29% | 23 |
|